![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig2_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer | Experimental oncology Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer | Experimental oncology](http://exp-oncology.com.ua/wp/wp-content/uploads/2019/09/wpid-2633_fig_201_fmt.jpeg)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer | Experimental oncology
![Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients - ecancer Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients - ecancer](https://ecancer.org/es/journal/article/site/data/images/article/306/can-7-305fig3.gif)
Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients - ecancer
![Table 2 from Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients. | Semantic Scholar Table 2 from Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f9c0c105884a812b2d0cc67de3976a7cbdc75412/4-Table2-1.png)
Table 2 from Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients. | Semantic Scholar
![Breast cancer statistics and markers Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P - J Can Res Ther Breast cancer statistics and markers Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P - J Can Res Ther](https://www.cancerjournal.net/articles/2014/10/3/images/JCanResTher_2014_10_3_506_137927_t5.jpg)
Breast cancer statistics and markers Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P - J Can Res Ther
Tumor markers in breast cancer follow-up: A potentially useful parameter still awaiting definitive assessment
![Table 5 from Value of CA 15.3 in breast cancer and comparison with CEA and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the Table 5 from Value of CA 15.3 in breast cancer and comparison with CEA and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the](https://d3i71xaburhd42.cloudfront.net/53d2361e63ad0e20503480521d2be53a76909589/6-Table5-1.png)
Table 5 from Value of CA 15.3 in breast cancer and comparison with CEA and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the
![Table 4 from Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. | Semantic Scholar Table 4 from Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1736ec52d40583bb7ee79b3f1cfc8b5cd2eb1cdc/6-Table4-1.png)
Table 4 from Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. | Semantic Scholar
![Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 51 Issue 7 (2013) Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 51 Issue 7 (2013)](https://www.degruyter.com/view/journals/cclm/51/7/graphic/cclm-2012-0488_fig2.jpg)